Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest

Molecular and Cellular Biology

Volumn 16, Issue 7, 1996, Pages 3934-3944

  Tiefenbrun, Nava ^a   Melamed, Dror ^a   Levy, Naomi ^a   Resnitzky, Dalia ^a,b   Hoffmann, Ingrid ^c   Reed, Steven I ^b   Kimchi, Adi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLINE; MESSENGER RNA; PHOSPHATASE; VINCULIN;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0029997033     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.7.3934     Document Type: Article

References (41)

1. Burke, L. B., A. Bybee, and N. S. B. Thomas. 1992. The retinoblastoma protein is partially phosphorylated during early G1 in cycling cells but not in G1 cells arrested with α-interferon. Oncogene 7:783-788.
2. DeCaprio, J. A., Y. Furukawa, F. Ajchenbaum, J. D. Griffin, and D. M. Livingston. 1992. The retinohlastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89:1795-1798.
3. DeCaprio, J. A., J. W. Ludlow, D. Lynch, V. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
4. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
5. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961.
6. 1 arrest. Nature (London) 313:597-600.
7. Elledge, S. J., and J. W. Harper. 1994. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6:847-852.
8. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
9. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020.
10. Geng, V., and R. A. Weinberg. 1993. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315-10319.
11. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
12. ink4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (London) 371:257-260.
13. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
14. Hinds, P. W. 1995. The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dcv. 5:79-83.
15. Hoffmann, I., G. Draetta, and E. Karsenti. 1994. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:4302-4310.
16. cdc2 phosphorylation and histone HI kinase activity is associated with G1/S-phase growth arrest. Mol. Cell. Biol. 11:1185-1194.
17. Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1549-1556.
18. Kimchi, A. 1992. Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50:1-9.
19. Kimchi, A., D. Resnitzky, R. Ber, and G. Gat. 1988. Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis. Mol. Cell. Biol. 8:2828-2836.
20. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260:536-539.
21. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β is linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
22. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin/cdk2 and cyclin A/cdk2 kinases associate with p107 und E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
23. Levy., N., E. Yonish-Rouach, M. Oren, and A. Kimchi. 1993. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Mol. Cell. Biol. 13:7942-7952.
24. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
25. Melamed, D., N. Tlefenbrun, A. Yarden, and A. Kimchi. 1993. Interferons and interleukin-6 suppress the DNA-hinding activity of E2F in growth-sensitive hematopoietic cells. Mol. Cell. Biol. 13:5255-5265.
26. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897-906.
27. Millar, J. B., C. H. McGowan, G. Lenaers, R. Jones, and P. Russell. 1991. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J. 10:4301-4309.
28. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
29. Pietenpol, J. A., R. W. Stein, E. Moram, P. Yaluk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGF-β inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
30. Polyak, K., M. H. Lee, B. H. Erdjument, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
31. Reed, S. I. 1992. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8:529-561.
32. 1/S phase transition by expression of cyclins D1and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
33. 1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells. Cell Growth Differ. 2:33-41.
34. Resnitzky, D., N. Tiefenbran, H. Berissi, and A. Kimchi. 1992. Interferons and inlerleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA 89:402-406.
35. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
36. Tiefenbrun, N., and A. Kimchi. 1991. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells. Oncogene 6:1001-1007.
37. Tonks, N. K., C. D. Diltz, and E. H. Fischer. 1988. Purification of the major protein-tyrosine phosphatase of human placenta. J. Biol. Chem. 263:6722-6730.
38. Tsai, L. H., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8:1593-1602.
39. Won, K.-A., and S. I. Reed. EMBO J., in press.
40. Yarden, A., and A. Kimchi. 1986. Tumor necrosis factor reduces c-myc expression and cooperates with IFN-γ in HeLa cells. Science 243:1419-1421.
41. Yonish-Rouach, E., D. Resnitzky, Y. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.